Albemarle Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Albemarle (ALB) Stock Looks Below Fair Value After A 67% Gain

AI-generated analysis

📈 Albemarle stock has delivered a 67% return over the past year, significantly outperforming recent market trends.

💰 A Discounted Cash Flow (DCF) model estimates an intrinsic value of $251.89 per share, implying the stock is undervalued by 47.3% based on projected future cash flows.

📉 The current Price-to-Sales ratio of 2.7x is substantially higher than the industry average of 1.1x and peer group average of 2.5x, flagging potential overvaluation.

🔋 Projected free cash flow is expected to grow from $619.1 million in the latest twelve months to $1.4 billion by 2030.

🤝 Approximately 50% of Albemarle's sales volumes are locked under long-term agreements with major Western OEM and battery customers, ensuring revenue stability.

⚠️ Risks include ongoing global lithium supply expansions and visible overcapacity in Chinese conversion facilities which could lead to market surplus.

📊 The company faces a valuation split where intrinsic value models suggest upside while market multiples indicate the stock is trading at a premium.

Bullish Signals
  • A Discounted Cash Flow (DCF) model projects an intrinsic value of $251.89 per share, indicating the stock is undervalued by approximately 47.3% relative to current prices.
  • The company expects free cash flow to grow significantly from $619.1 million in the latest twelve months to a forecasted $1.4 billion by 2030.
  • Strong Q2 2026 earnings are anticipated, supported by firm lithium pricing and higher production volumes.
  • Approximately 50% of sales volumes are secured under long-term agreements with major Western OEMs and battery customers, providing enhanced revenue stability.
Risk Factors
  • The current Price-to-Sales ratio of 2.7x is meaningfully higher than the Chemicals industry average of 1.1x and the peer group average of 2.5x, suggesting overvaluation.
  • Ongoing global lithium supply expansions combined with visible overcapacity in Chinese conversion facilities point to intensifying commoditization risks.
Full Analysis
Albemarle (ALB) stock has surged 67% over the past year, creating a valuation divergence between different analytical frameworks. A Discounted Cash Flow (DCF) model projects an intrinsic value of approximately $251.89 per share, suggesting the current price is undervalued by roughly 47.3%. This bullish view relies on strong Q2 2026 earnings expectations driven by firm lithium pricing and increased volumes, with free cash flow projected to grow from $619.1 million recently to $1.4 billion by 2030. However, market multiple metrics indicate the stock is expensive relative to peers and historical averages. The current Price-to-Sales (P/S) ratio stands at 2.7x, significantly higher than the Chemicals industry average of 1.1x and the peer group average of 2.5x. The model implies a fair P/S ratio of only 1.9x, suggesting investors are paying a premium that may not be fully justified by current fundamentals or growth profiles. Community sentiment regarding Albemarle is sharply divided between two narratives. The bull case highlights revenue stability provided by long-term agreements covering approximately 50% of sales volumes with major Western OEMs and battery customers. Conversely, the bear case points to intensifying commoditization risks due to global lithium supply expansions, visible overcapacity in Chinese conversion facilities, and periods of market surplus.